Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Clinical trial NCT02059135 · COMPLETED
Trial details
- NCT number
- NCT02059135
- Sponsor
- rEVO Biologics
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-11
- Primary completion
- 2016-05-18
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.